Document is current

Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

Crossref DOI link: https://doi.org/10.1136/bmjgast-2019-000302corr1

Published Online: 2020-02-20

Published Print: 2020-02

Update policy: https://doi.org/10.1136/crossmarkpolicy